Tranexamic acid (TXA) has revolutionized modern blood management in orthopaedic
surgery, especially in total joint arthroplasty, by significantly reducing blood loss and …

Background Tranexamic acid (TXA) has been used surgically to decrease blood loss. The
ability of TXA to improve arthroscopic visualization and allow for reduction in pump pressure …

Introduction Tranexamic acid (TXA) has been shown to be effective at reducing peri-
operative blood loss and haemarthrosis in arthroplasty and arthroscopic soft tissue …

Background: Posttraumatic osteoarthritis (OA) is a common disorder associated with a high
socioeconomic burden, particularly in young, physically active, and working patients …

Background Tranexamic acid (TXA) is an antifibrinolytic agent applied in orthopedic surgery
and has been proven to reduce post-surgery infection rates. We previously showed that TXA …

Background Dysregulated inflammatory responses are implicated in the pathogenesis of
joint stiffness and arthrofibrosis following total knee arthroplasty (TKA). The purpose of this …

Osteoarthritis (OA) is the most common degenerative joint disease. Rapamycin is a potential
candidate for OA treatment by increasing the autophagy process implicated in its …

Background Several studies have shown that tranexamic acid (TXA), an antifibrinolytic,
reduces postoperative infection rates. Recent in vitro research showed that TXA alone and …

Objective In spinal surgery, considerable blood loss is increasingly treated with the local
application of tranexamic acid (TXA). However, little is known about its cytotoxicity and effect …

Background Knee arthroscopic arthrolysis serves as an effective treatment for knee
arthrofibrosis. However, hemarthrosis is the most common complication in arthroscopic …